The longevity supplement market is worth billions, and it's growing fast. Walk into any pharmacy or scroll through Instagram and you'll find NMN, resveratrol, spermidine, and a dozen other compounds promising to slow the clock. Most of them are backed by compelling animal data, enthusiastic influencers, and not much else.
In November 2026, researchers at Yale University published a comprehensive analysis of 51 anti-aging interventions spanning prescription drugs, over-the-counter supplements, dietary patterns, and exercise protocols. The goal was straightforward: assess which interventions have credible human evidence behind them and which are still riding on hype. The findings are worth reading carefully before you spend another dollar on a longevity stack.
How the Analysis Was Structured
The Yale team evaluated interventions across several categories of evidence quality. Human clinical trials, particularly randomized controlled trials, carried the most weight. Observational studies in humans ranked below that. Animal or in vitro data alone, no matter how promising, was treated as preliminary rather than actionable.
The 51 interventions included compounds like metformin, rapamycin, NMN, NAD+ precursors, resveratrol, spermidine, and omega-3s on the supplement side. On the lifestyle side, researchers examined caloric restriction, Mediterranean-style eating, time-restricted feeding, aerobic exercise, resistance training, and high-intensity interval protocols. The breadth of the review is what makes it useful. It doesn't compare supplements against each other. It compares everything against everything.
The Supplement Picture Is Messier Than You Think
Here's the uncomfortable finding most longevity brands don't want to discuss: the majority of commercially popular anti-aging supplements have weak or insufficient human evidence to support the specific claims made about them.
NMN and other NAD+ precursors, for example, do raise NAD+ levels in human blood. That part is established. But whether elevated NAD+ translates into measurable longevity benefits in humans remains unproven. The mechanistic story is plausible. The clinical outcome data isn't there yet.
Resveratrol follows a similar pattern. Rodent studies are genuinely interesting. Human bioavailability is poor, and clinical trials haven't replicated the dramatic effects seen in animals. Spermidine has some early human data suggesting benefits on cardiovascular and cognitive markers, but sample sizes are small and follow-up periods are short.
The review did identify a small subset of compounds with more meaningful human evidence. Omega-3 fatty acids showed consistent associations with reduced cardiovascular mortality across large population studies. Vitamin D, when correcting a deficiency, produced measurable reductions in all-cause mortality risk. And metformin, a prescription diabetes drug, has accumulated enough longevity-adjacent evidence in humans that a major clinical trial is currently underway to test it directly in non-diabetic older adults.
That doesn't mean the rest are useless. It means the evidence isn't yet strong enough to justify confident recommendations for healthy adults chasing longevity specifically. If you're taking NMN or spermidine and tolerating them well, you're not necessarily doing something wrong. You're just running ahead of the science.
Diet Outperforms Most Pills
Dietary patterns consistently ranked among the highest-evidence interventions in the Yale analysis. Caloric restriction has the strongest mechanistic and human data of anything reviewed. Reducing caloric intake without malnutrition activates multiple longevity pathways simultaneously, including AMPK signaling, reduced IGF-1, and autophagy induction. A two-year randomized trial in healthy adults found that modest caloric restriction of around 12 percent below baseline produced significant improvements in cardiometabolic risk markers and biological aging indicators.
Time-restricted eating, particularly eating windows of 8 to 10 hours aligned with daylight hours, showed consistent benefits on metabolic health markers and some biological aging indicators. The evidence isn't quite as robust as for caloric restriction, but it's accumulating steadily across human trials.
Mediterranean-style dietary patterns, characterized by high intake of vegetables, legumes, fish, olive oil, and whole grains, repeatedly appeared in the highest-evidence tier. Population-level data linking this eating pattern to reduced all-cause mortality is among the most replicated in nutritional epidemiology. It's not sexy, but it's solid.
One consistent theme across the dietary findings: overall dietary quality and energy balance matter more than any single nutrient or compound. If you're eating in a large caloric surplus, adding a longevity supplement to the stack doesn't fix the foundational problem. This connects to broader discussions in sports nutrition about how total energy status shapes virtually every health outcome, something worth reading about if you train seriously. REDs: The Hidden Energy Deficit Killing Your Performance examines how chronic energy imbalance disrupts the systems anti-aging research is trying to optimize.
Exercise Protocols: Intensity and Variety Both Matter
Exercise emerged as the single strongest category of intervention across the full Yale review. The finding isn't surprising, but the specifics are worth unpacking.
Aerobic fitness, measured by VO2max, is one of the strongest independent predictors of longevity in human data. Each meaningful improvement in VO2max is associated with substantial reductions in all-cause mortality risk, with some analyses suggesting effects larger than those associated with quitting smoking. That positions exercise not as a supplement to good health habits but as one of the most potent longevity tools available to anyone who can use it.
High-intensity interval training showed particular efficiency in improving VO2max relative to time invested. If you're wondering whether the frequency of your HIIT sessions matters as much as the sessions themselves, the research is nuanced. HIIT Once vs. Three Times a Week: What's the Real Difference? breaks down what the frequency research actually shows for both VO2max gains and fat loss outcomes.
Resistance training adds a distinct set of longevity benefits that aerobic work doesn't fully cover: muscle mass preservation, bone density maintenance, glucose metabolism improvements, and reduced fall risk in older adults. The Yale analysis treated these as complementary, not competing priorities. The ideal protocol for longevity almost certainly involves both.
Bone health deserves specific attention here. The review flagged skeletal integrity as a longevity marker that gets underweighted in popular anti-aging conversations. Standard lifting routines don't always generate the bone-stimulating signals that high-impact or plyometric work does. Your Bones Need More Than Lifting to Stay Strong covers why the type of mechanical load matters, not just whether you're lifting.
For women navigating perimenopause and menopause, the exercise picture becomes more specific. Hormonal changes alter how muscle and bone respond to training, which means generic protocols need adjustment. Strength Training Through Menopause: What to Change addresses what that adaptation looks like in practice.
Sleep and Recovery: The Underrated Tier
The Yale review included sleep quality and quantity as a longevity intervention, and the evidence placed it firmly in the high-confidence tier. Chronic sleep deprivation is associated with accelerated biological aging, increased all-cause mortality, and impaired clearance of metabolic waste products from the brain. This isn't minor. It's one of the most dose-responsive relationships in longevity research.
Seven to nine hours of sleep per night remains the well-supported target for most adults. The mechanisms include hormonal regulation, immune function, cellular repair, and neurological waste clearance. How Sleep Actually Clears Waste From Your Brain explains the glymphatic system and why disrupted sleep is a genuine neurological risk factor, not just a performance inconvenience.
Recovery as a category also emerged as more evidence-supported than the supplement industry would like. If you're stacking longevity compounds but sleeping six hours a night and training without adequate recovery, you're managing around a problem rather than solving it.
What to Actually Do With This
The Yale analysis doesn't recommend abandoning all supplements or dismissing the research coming out of longevity science. What it does is establish a priority order that most people currently have inverted.
The interventions with the strongest human evidence are, in rough order of effect size and consistency: regular aerobic exercise prioritizing VO2max improvements, resistance training for muscle and bone, high-quality sleep, a Mediterranean-style or calorie-conscious dietary pattern, and correction of documented micronutrient deficiencies like vitamin D.
After that foundation is solid, there's a reasonable case for exploring supplements with early but promising human data. Omega-3s have strong enough evidence to sit alongside the lifestyle fundamentals. The others warrant monitoring as the science develops.
The supplements generating the most marketing attention, NMN, resveratrol, and similar compounds, may yet prove their value in human trials. The data will come. Right now, they represent speculative bets, not established interventions. That distinction matters when you're deciding where to put your time, money, and attention.
Longevity research is moving fast, and the recommendations will evolve. But the Yale review makes one thing hard to dispute: the basics work, they're accessible, and they're being systematically outspent and outshouted by the supplement industry. Don't let the noise drown out the signal.